Literature DB >> 11309194

Peroxisomal targeting of mammalian hydroxyacid oxidase 1 requires the C-terminal tripeptide SKI.

S Recalcati1, E Menotti, L C Kühn.   

Abstract

Peroxisomal proteins are post-translationally imported into peroxisomes after recognition by specific receptors. The best-defined peroxisomal targeting signal is a C-terminal tripeptide SKL. Different functional variants of this tripeptide have been defined, but mutants with a SKI sequence were recognized as being inefficiently targeted to peroxisomes. Recently, we have cloned a cDNA for the mouse hydroxyacid oxidase 1 (Hao1), a protein that seems to be localized in peroxisomes. Interestingly, the mouse Hao1 sequence comprises a C-terminal SKI tripeptide. We have analyzed the subcellular localization of Hao1 and tested whether its SKI sequence acts as a targeting signal. Ltk(-) and Cos-7 cells were transfected with vectors expressing a fusion protein of green fluorescence protein and Hao1, as well as mutants thereof. Targeting to peroxisomes of the fusion protein with the wild-type SKI sequence was highly selective and as complete as with the peroxisome-specific SKL sequence. By contrast, targeting was lost in a mutant with the sequence CKM. The data show that mammalian Hao1 is a peroxisomal protein and that the C-terminal sequence SKI acts as the targeting signal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309194     DOI: 10.1242/jcs.114.9.1625

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  3 in total

1.  Localized transfection on arrays of magnetic beads coated with PCR products.

Authors:  Mark Isalan; Maria Isabel Santori; Cayetano Gonzalez; Luis Serrano
Journal:  Nat Methods       Date:  2005-01-21       Impact factor: 28.547

Review 2.  Peroxisomal Metabolite and Cofactor Transport in Humans.

Authors:  Serhii Chornyi; Lodewijk IJlst; Carlo W T van Roermund; Ronald J A Wanders; Hans R Waterham
Journal:  Front Cell Dev Biol       Date:  2021-01-11

3.  Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria.

Authors:  Tracy L McGregor; Karen A Hunt; Elaine Yee; Dan Mason; Paul Nioi; Simina Ticau; Marissa Pelosi; Perry R Loken; Sarah Finer; Deborah A Lawlor; Eric B Fauman; Qin Qin Huang; Christopher J Griffiths; Daniel G MacArthur; Richard C Trembath; Devin Oglesbee; John C Lieske; David V Erbe; John Wright; David A van Heel
Journal:  Elife       Date:  2020-03-24       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.